CHRU de Brest
Brest, 29609, France
NCT Number: NCT05094349
Prognosis of subarachnoid hemorrhage (SAH) is scarce, indeed almost half patients die or become severely disable after SAH. Outcome is related to the severity of the initial bleeding and delayed cerebral infarction (DCI). Infection and more precisely pneumonia have been associated with poor outcome in SAH. However, the interaction between the two pathologic events remains unclear. Therefore, we hypothesized that DCI may be associated to pneumonia in SAH patients. Thus the aim of the study is to analyze the association between delayed cerebral infarction and pneumonia in patients with SAH.
Retrospective, observational, monocentric cohort study, including patient admitted in Neurosurgical Intensive Care Unit or Surgical Intensive Care Unit in the University Hospital of Brest (France) for non-traumatic SAH. Primary outcome is diagnosis of DCI on CT scan or MRI 3 months after SAH. Multivariate analysis is used to identify factors independently associated with DCI.
We plan to include between 200 and 250 patients in the analysis.
Looking for future studies?
Notify MeAll sexes
Observational
Brest, 29609, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months from subarachnoid hemorrhage
infarction on CT or MRI not related to initial bleeding
University Hospital, Brest
Other
Influence of Pneumonia on Delayed Cerebral Infarction After Subarachnoid Hemorrhage: a Retrospective Study
Acronym: SAH-CIP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02894034
Brain Diseases, Cardiovascular Diseases
Amiens, France
View Trial DetailsNCT03655509
Brain Diseases, Cardiovascular Diseases
Rennes, France
View Trial DetailsNCT04042571
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT06797765
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial Details